The FDA granted Becton Dickinson 510(k) clearance for its BD FACSLyric flow cytometer system, which is designed to be used with BD Multitest assays for use in immunological assessments of individuals with suspected or confirmed immune deficiency. The company said its system delivers repeatable and accurate results through the combination of a benchtop-sized instrument with reagents, software and services.
BD's flow cytometer system wins FDA clearance
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.